Afferent Pharmaceuticals' Series A Round

Afferent Pharmaceuticals raised a round of funding on December 11, 2009.

Afferent Pharmaceuticals is a clinical-stage biotechnology company and specializing in the development of therapeutic candidates targeting the P2X3 receptor for the treatment of common, poorly-managed…

Articles about Afferent Pharmaceuticals' Series A Round: